Pirotzky E, Delattre R M, Hellegouarch A, Lonchampt M O, Aarden L, Braquet P, Galanaud P
IHB Research Laboratories, Les Ulis, France.
Clin Immunol Immunopathol. 1990 Aug;56(2):271-9. doi: 10.1016/0090-1229(90)90148-j.
Interleukin-6 (IL-6) is produced by various cell types, including monocytes, fibroblasts, and endothelial cells. IL-6 has also been detected in the urine of normal and renal transplant patients. Thus, the possible production of this cytokine by glomeruli and mesangial cells was investigated. Rat glomeruli were obtained by serial sieving of cortical homogenates of blood-free kidneys. Mesangial cells were obtained from the glomeruli and cultured under standard methods in RPMI 1640 medium containing 15% fetal calf serum. Glomeruli or confluent monolayers cells were then incubated in RPMI 1640 for 18 hr, in the presence or not of tumor necrosis factor-alpha (TNF alpha), lipopolysaccharide (LPS), or platelet-activating factor (PAF). IL-6 activity was measured using the IL-6-dependent cell line subclone (B 9-9) and expressed with respect to a standard curve established with recombinant IL-6. Glomeruli generate IL-6 upon TNF alpha (100 ng/ml) and LPS (1 microgram/ml), 11,500 +/- 3000 and 22,000 +/- 7500 U/ml, respectively. Nonstimulated mesangial cells produced 50 +/- 5 U/ml (mean +/- SEM, n = 4) of IL-6. TNF alpha (1 ng/ml) and LPS (1 microgram/ml) induced the production of 800 +/- 90 and 40,000 +/- 5000 U/ml, respectively (n = 4). In contrast, PAF (0.1 nM-1 microM) did not increase IL-6 production from glomeruli or mesangial cells. These results demonstrate that renal cells spontaneously generate minimal amounts of IL-6 and that this production is significantly increased by TNF alpha or LPS. A synergy between LPS and TNF alpha was induced in glomerular cells with 10 ng/ml of TNF alpha and graded concentrations of LPS. Thus, the production of IL-6 by glomerular cells and its modulation by other cytokines or endotoxins may play a role in the local immunological processes leading to immune glomerular diseases.
白细胞介素-6(IL-6)由多种细胞类型产生,包括单核细胞、成纤维细胞和内皮细胞。在正常人和肾移植患者的尿液中也检测到了IL-6。因此,研究了肾小球和系膜细胞产生这种细胞因子的可能性。通过对无血肾脏的皮质匀浆进行连续筛分获得大鼠肾小球。从肾小球中获取系膜细胞,并在含有15%胎牛血清的RPMI 1640培养基中采用标准方法进行培养。然后将肾小球或汇合的单层细胞在RPMI 1640中孵育18小时,分别在有或无肿瘤坏死因子-α(TNFα)、脂多糖(LPS)或血小板活化因子(PAF)的情况下进行。使用依赖IL-6的细胞系亚克隆(B 9-9)测量IL-6活性,并相对于用重组IL-6建立的标准曲线进行表达。肾小球在TNFα(100 ng/ml)和LPS(1μg/ml)作用下分别产生IL-6,产量为11,500±3000 U/ml和22,000±7500 U/ml。未受刺激的系膜细胞产生50±5 U/ml(平均值±标准误,n = 4)的IL-6。TNFα(1 ng/ml)和LPS(1μg/ml)分别诱导产生800±90 U/ml和40,000±5000 U/ml(n = 4)。相比之下,PAF(0.1 nM - 1μM)并未增加肾小球或系膜细胞的IL-6产量。这些结果表明,肾细胞自发产生极少量的IL-6,并且TNFα或LPS可显著增加其产量。在肾小球细胞中,10 ng/ml的TNFα与不同浓度的LPS之间可诱导LPS与TNFα的协同作用。因此,肾小球细胞产生IL-6及其受其他细胞因子或内毒素的调节可能在导致免疫性肾小球疾病的局部免疫过程中起作用。